Report: FDA’s Review of Moderna’s mRNA Flu Vaccine Concealed Statistically Significant Safety Signal

Estimated read time 1 min read

(NaturalNews) The Food and Drug Administration (FDA) on Aug. 6 licensed Moderna’s mRNA influenza vaccine, mFLUSIVA, for adults 50 and older – marking the first …

You May Also Like

More From Author